Health

Related media - News 24 hours Ann Lurie, a former pediatric nurse turned prominent Chicago philanthropist, died Monday at her home. She was 79. Northwestern University, where Lurie was a trustee and major donor, announced her death without giving a cause. Raised in Miami by a single mother, Lurie was an only child and protested the Vietnam War during her college years. She initially planned to join the Peace Corps, but instead married Robert H. Lurie. Robert Lurie built a large real estate and investment business with Sam Zell, which included holdings such as The Chicago Tribune and the Chicago Cubs. He also invested in sports teams such as the Chicago Bulls and the White Sox. Robert Lurie died of colon cancer in 1990, leaving behind an estate valued at $425 million. Ann Lurie, who e...

More news - Recent news The Centers for Disease Control and Prevention (CDC) announced Thursday that all Americans aged 6 months and older should receive one of the new COVID-19 vaccines as soon as they become available this fall. This recommendation comes amid a summer surge in COVID-19 cases, with infection rates rising in at least 39 states and territories. While most Americans have developed some immunity to the coronavirus through previous infections or vaccinations, the new vaccines offer an incremental boost. However, their effectiveness wanes over a few months as immunity wanes and the virus continues to mutate. Data presented at a recent meeting of the CDC’s Advisory Committee on Immunization Practices showed that most Americans hospitalized for COVID-19 had not received t...

More news - Recent news For many Americans, the rising tide of prescription drug prices seems like a relentless force, threatening to swamp family budgets and access to health care. While pharmaceutical companies often assume public responsibility, the web of influences on drug costs is much more intricate. Today we shine our spotlight on a critical, but typically hidden, player in this system: pharmacy benefit managers, or PBMs. Rebecca Robbins, a leading investigative reporter specializing in pharmaceuticals for the New York Times, takes us on a deep dive into the world of PBMs. We explore their role as middlemen between drugmakers, insurers, pharmacies and, ultimately, patients. This complex dance can have a significant impact on how much you pay for your medicati...

More news - News 24 hours Mosquito-borne dengue fever is spreading rapidly around the world, reaching record levels and even popping up in unexpected places. The Centers for Disease Control and Prevention (CDC) is warning doctors in the United States to watch out for cases, as the risk of infection has increased this year. Why the surge? Several factors are driving the increase in dengue. The Aedes a Egypti mosquito, which transmits the virus, thrives in warm, humid environments. Climate change is creating the ideal conditions for these mosquitoes to expand their range and become more numerous. Additionally, urbanization brings people closer to mosquito breeding grounds, increasing the chance of bites. A global problem While tropical countries like Brazil have long battled dengue...

Related media - Latest news It can take years before generic drug makers are ready to produce a drug, and they need to have an idea of ​​the potential market to commit to investing in production. So, in the meantime, Gilead will aim to ship “sufficient volumes” of lenacapavir to lower-income countries as soon as it wins regulatory approval, he said. Lenacapavir and the two pills studied are all known as pre-exposure prophylaxis, or PrEP, drugs. Another effective injectable PrEP drug is available in some African countries, but its introduction has been plagued by access problems. Long-acting cabotegravir, given by injection every two months, has also shown excellent results in clinical trials in Africa. It is produced by ViiV Healthcare, owned by pharmaceutical giant GSK;...

More news - Breaking news “In a creative environment there is an encounter with yourself, an awakening to your unconscious, to your experiences,” said Tammy Federman, a filmmaker whose new documentary “Memory Game” centers on a theater troupe of survivors of Holocaust in Israel managed by AMCHA, an Israeli social support services organization. “But there's also a group meeting because one person talks about this very traumatic experience and another person can relate to it. It gives you the courage to open up, to share your experience, and there is also joy, there is humor, there is movement and creativity.” And while research from Brandeis University and IMPACT, a non-profit organization born out of a Brandeis initiative, found that creative sector efforts tackling tough challenge...